To verify that the up-regulation of PD-L1 in tumor cells is a direct effect of the IFNγ present in the TME, we treated SM1 melanoma cells in vitro with NextA or vehicle control and then co-cultured with CD3/CD28 activated splenocytes in the presence of anti-PD1 antibody. This evidence concerns the gene CD28 and melanoma.